{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:34:52Z","timestamp":1773426892076,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03480-y","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T08:34:15Z","timestamp":1741941255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of macular edema recurrence and visual outcomes in branch retinal vein occlusion treated with aflibercept or ranibizumab"],"prefix":"10.1007","volume":"45","author":[{"given":"Jung-Tzu","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Wen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Cheng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-lien","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"3480_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","volume":"117","author":"S Rogers","year":"2010","unstructured":"Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P et al (2010) The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117:313-319.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2009.07.017","journal-title":"Ophthalmology"},{"key":"3480_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ophtha.2012.09.033","volume":"120","author":"JQ Zhou","year":"2013","unstructured":"Zhou JQ, Xu L, Wang S, Wang YX, You QS, Tu Y et al (2013) The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology 120:803\u2013808. https:\/\/doi.org\/10.1016\/j.ophtha.2012.09.033","journal-title":"Ophthalmology"},{"key":"3480_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/s0161-6420(83)34542-5","volume":"90","author":"SS Hayreh","year":"1983","unstructured":"Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF (1983) Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90:488\u2013506. https:\/\/doi.org\/10.1016\/s0161-6420(83)34542-5","journal-title":"Ophthalmology"},{"key":"3480_CR4","doi-asserted-by":"publisher","first-page":"4936924","DOI":"10.1155\/2017\/4936924","volume":"2017","author":"J Li","year":"2017","unstructured":"Li J, Paulus YM, Shuai Y, Fang W, Liu Q, Yuan S (2017) New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion. J Ophthalmol 2017:4936924. https:\/\/doi.org\/10.1155\/2017\/4936924","journal-title":"J Ophthalmol"},{"key":"3480_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22:42\u201348. https:\/\/doi.org\/10.1038\/sj.eye.6702498","journal-title":"Eye (Lond)"},{"key":"3480_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/bjo.2010.192468","volume":"95","author":"H Noma","year":"2011","unstructured":"Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K (2011) Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Br J Ophthalmol 95:788\u2013792. https:\/\/doi.org\/10.1136\/bjo.2010.192468","journal-title":"Br J Ophthalmol"},{"key":"3480_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1006\/exer.2002.2042","volume":"75","author":"AH Neufeld","year":"2002","unstructured":"Neufeld AH, Kawai S, Das S, Vora S, Gachie E, Connor JR et al (2002) Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp Eye Res 75:521\u2013528. https:\/\/doi.org\/10.1006\/exer.2002.2042","journal-title":"Exp Eye Res"},{"key":"3480_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/bjophthalmol-2015-308106","volume":"100","author":"RA Alshareef","year":"2016","unstructured":"Alshareef RA, Barteselli G, You Q, Goud A, Jabeen A, Rao HL et al (2016) In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion. Br J Ophthalmol 100:1506\u20131510. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308106","journal-title":"Br J Ophthalmol"},{"key":"3480_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00417-014-2731-2","volume":"253","author":"HM Kang","year":"2015","unstructured":"Kang HM, Koh HJ, Lee SC (2015) Visual outcome and prognostic factors after surgery for a secondary epiretinal membrane associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 253:543\u2013550. https:\/\/doi.org\/10.1007\/s00417-014-2731-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1102\u20131112","key":"3480_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.021","volume":"117","author":"PA Campochiaro","year":"2010","unstructured":"Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC et al (2010) Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117(1102\u20131112):e1. https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.021","journal-title":"Ophthalmology"},{"key":"3480_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","volume":"123","author":"WL Clark","year":"2016","unstructured":"Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R et al (2016) Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study. Ophthalmology 123:330\u2013336. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.035","journal-title":"Ophthalmology"},{"key":"3480_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/IAE.0000000000001224","volume":"37","author":"Y Miwa","year":"2017","unstructured":"Miwa Y, Muraoka Y, Osaka R, Ooto S, Murakami T, Suzuma K (2017) Ranibizumab for macular edema after branch retinal vein occlusion: one initial injection versus three monthly injections. Retina 37:702\u2013709. https:\/\/doi.org\/10.1097\/IAE.0000000000001224","journal-title":"Retina"},{"key":"3480_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41598-023-28533-z","volume":"13","author":"H Noma","year":"2023","unstructured":"Noma H, Yasuda K, Narimatsu A, Asakage M, Shimura M (2023) New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema. Sci Rep 13:1536. https:\/\/doi.org\/10.1038\/s41598-023-28533-z","journal-title":"Sci Rep"},{"key":"3480_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000451062","volume":"236","author":"H Noma","year":"2016","unstructured":"Noma H, Mimura T, Yasuda K, Nakagawa H, Motohashi R, Kotake O et al (2016) Cytokines and recurrence of macular edema after intravitreal ranibizumab in patients with branch retinal vein occlusion. Ophthalmologica 236:228\u2013234. https:\/\/doi.org\/10.1159\/000451062","journal-title":"Ophthalmologica"},{"key":"3480_CR15","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1097\/IAE.0000000000003118","volume":"41","author":"GW Lee","year":"2021","unstructured":"Lee GW, Kang SW, Kang MC, Kim SJ, Kim YY (2021) Associations with recurrence of macular edema in branch retinal vein occlusion after the discontinuation of anti vascular endothelial growth factor. Retina 41:1892\u20131900. https:\/\/doi.org\/10.1097\/IAE.0000000000003118","journal-title":"Retina"},{"key":"3480_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ajo.2023.01.004","volume":"249","author":"G Yiu","year":"2023","unstructured":"Yiu G, Huang D, Wang Y, Wang Z, Yang M, Haskova Z (2023) Predictors of as-needed ranibizumab injection frequency in patients with macular edema following retinal vein occlusion. Am J Ophthalmol 249:74\u201381. https:\/\/doi.org\/10.1016\/j.ajo.2023.01.004","journal-title":"Am J Ophthalmol"},{"key":"3480_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6096017","author":"S Fragiotta","year":"2021","unstructured":"Fragiotta S, Abdolrahimzadeh S, Dolz-Marco R, Sakurada Y, Gal-Or O, Scuderi G (2021) Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications. J Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/6096017","journal-title":"J Ophthalmol"},{"key":"3480_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/bjophthalmol-2020-317615","volume":"106","author":"J Wang","year":"2022","unstructured":"Wang J, Cui Y, Vingopoulos F, Kasetty M, Silverman RF, Katz R et al (2022) Disorganisation of retinal inner layers is associated with reduced contrast sensitivity in retinal vein occlusion. Br J Ophthalmol 106:241\u2013245. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317615","journal-title":"Br J Ophthalmol"},{"key":"3480_CR19","doi-asserted-by":"publisher","first-page":"14103","DOI":"10.1038\/s41598-022-18414-2","volume":"12","author":"YJ Choi","year":"2022","unstructured":"Choi YJ, Jee D, Kwon JW (2022) Characteristics of major and macular branch retinal vein occlusion. Sci Rep 12:14103. https:\/\/doi.org\/10.1038\/s41598-022-18414-2","journal-title":"Sci Rep"},{"key":"3480_CR20","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/IAE.0000000000002264","volume":"39","author":"L Yeung","year":"2019","unstructured":"Yeung L, Wu WC, Chuang LH, Wang NK, Lai CC (2019) Novel optical coherence tomography angiography biomarker in branch retinal vein occlusion macular edema. Retina 39:1906\u20131916. https:\/\/doi.org\/10.1097\/IAE.0000000000002264","journal-title":"Retina"},{"key":"3480_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12886-022-02245-w","volume":"22","author":"PW Huang","year":"2022","unstructured":"Huang PW, Lai CC, Hwang YS, Wu WC, Wu CH, Huang JC et al (2022) Treatment responses for branch retinal vein occlusion predicted by semi-automated fluorescein angiography quantification. BMC Ophthalmol 22:50. https:\/\/doi.org\/10.1186\/s12886-022-02245-w","journal-title":"BMC Ophthalmol"},{"key":"3480_CR22","doi-asserted-by":"publisher","first-page":"8945467","DOI":"10.1155\/2022\/8945467","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Gu X, Song S, Yu X, Zhang P, Dai H (2022) Structural and visual changes in branch retinal vein occlusion patients with retinal atrophy. J Ophthalmol 2022:8945467. https:\/\/doi.org\/10.1155\/2022\/8945467","journal-title":"J Ophthalmol"},{"key":"3480_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS et al (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121:209\u2013219. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.038","journal-title":"Ophthalmology"},{"key":"3480_CR24","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/s41598-019-42982-5","volume":"9","author":"Y Iida-Miwa","year":"2019","unstructured":"Iida-Miwa Y, Muraoka Y, Iida Y, Ooto S, Murakami T, Suzuma K et al (2019) Branch retinal vein occlusion: treatment outcomes according to the retinal nonperfusion area, clinical subtype, and crossing pattern. Sci Rep 9:6569. https:\/\/doi.org\/10.1038\/s41598-019-42982-5","journal-title":"Sci Rep"},{"key":"3480_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1055\/s-0041-108680","volume":"233","author":"T Groneberg","year":"2016","unstructured":"Groneberg T, Trattnig JS, Feucht N, Lohmann CP, Maier M (2016) Morphologic patterns on spectral-domain optical coherence tomography (SD-OCT) as a prognostic indicator in treatment of macular edema due to retinal vein occlusion. Klin Monbl Augenheilkd 233:1056\u20131062. https:\/\/doi.org\/10.1055\/s-0041-108680","journal-title":"Klin Monbl Augenheilkd"},{"key":"3480_CR26","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00417-010-1419-5","volume":"248","author":"AE Hoeh","year":"2010","unstructured":"Hoeh AE, Ruppenstein M, Ach T, Dithmar S (2010) OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 248:1567\u20131572. https:\/\/doi.org\/10.1007\/s00417-010-1419-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3480_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00417-014-2595-5","volume":"252","author":"JW Kang","year":"2014","unstructured":"Kang JW, Lee H, Chung H, Kim HC (2014) Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 252:1413\u20131421. https:\/\/doi.org\/10.1007\/s00417-014-2595-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3480_CR28","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.ophtha.2004.04.031","volume":"111","author":"H Ohashi","year":"2004","unstructured":"Ohashi H, Oh H, Nishiwaki H, Nonaka A, Takagi H (2004) Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion. Ophthalmology 111:2050\u20132056. https:\/\/doi.org\/10.1016\/j.ophtha.2004.04.031","journal-title":"Ophthalmology"},{"key":"3480_CR29","doi-asserted-by":"publisher","first-page":"e0199552","DOI":"10.1371\/journal.pone.0199552","volume":"13","author":"A Shiono","year":"2018","unstructured":"Shiono A, Kogo J, Sasaki H, Yomoda R, Jujo T, Tokuda N et al (2018) Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab. PLoS ONE 13:e0199552. https:\/\/doi.org\/10.1371\/journal.pone.0199552","journal-title":"PLoS ONE"},{"key":"3480_CR30","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1136\/bjo.2007.118497","volume":"91","author":"M Ota","year":"2007","unstructured":"Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A et al (2007) Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol 91:1644\u20131649. https:\/\/doi.org\/10.1136\/bjo.2007.118497","journal-title":"Br J Ophthalmol"},{"key":"3480_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00417-008-0866-8","volume":"246","author":"EJ Chung","year":"2008","unstructured":"Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241\u20131247. https:\/\/doi.org\/10.1007\/s00417-008-0866-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3480_CR32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.18240\/ijo.2016.06.12","volume":"9","author":"K Abri Aghdam","year":"2016","unstructured":"Abri Aghdam K, Reznicek L, Soltan Sanjari M, Framme C, Bajor A, Klingenstein A et al (2016) Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion. Int J Ophthalmol 9:858\u2013862. https:\/\/doi.org\/10.18240\/ijo.2016.06.12","journal-title":"Int J Ophthalmol"},{"key":"3480_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ajo.2013.05.039","volume":"156","author":"R Sophie","year":"2013","unstructured":"Sophie R, Hafiz G, Scott AW, Zimmer-Galler I, Nguyen QD, Ying H et al (2013) Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion. Am J Ophthalmol 156:693\u2013705. https:\/\/doi.org\/10.1016\/j.ajo.2013.05.039","journal-title":"Am J Ophthalmol"},{"key":"3480_CR34","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00417-021-05150-y","volume":"259","author":"DG Park","year":"2021","unstructured":"Park DG, Jeong WJ, Park JM, Kim JY, Ji YS, Sagong M (2021) Prospective trial of treat-and-extend regimen with aflibercept for branch retinal vein occlusion: 1-year results of the PLATON trial. Graefes Arch Clin Exp Ophthalmol 259:2879\u20132886. https:\/\/doi.org\/10.1007\/s00417-021-05150-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3480_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/OPTH.S37185","volume":"7","author":"S Sakimoto","year":"2013","unstructured":"Sakimoto S, Kamei M, Suzuki M, Yano S, Matsumura N, Sakaguchi H et al (2013) Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion. Clin Ophthalmol 7:39\u201345. https:\/\/doi.org\/10.2147\/OPTH.S37185","journal-title":"Clin Ophthalmol"},{"key":"3480_CR36","doi-asserted-by":"publisher","first-page":"101197","DOI":"10.1016\/j.xcrm.2023.101197","volume":"4","author":"X Zhao","year":"2023","unstructured":"Zhao X, Lin Z, Yu S, Xiao J, Xie L, Xu Y et al (2023) An artificial intelligence system for the whole process from diagnosis to treatment suggestion of ischemic retinal diseases. Cell Rep Med 4:101197. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101197","journal-title":"Cell Rep Med"},{"key":"3480_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjophthalmol-2014-305041","volume":"99","author":"H Gerding","year":"2015","unstructured":"Gerding H, Mones J, Tadayoni R, Boscia F, Pearce I, Priglinger S (2015) Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel. Br J Ophthalmol 99:297\u2013304. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305041","journal-title":"Br J Ophthalmol"},{"key":"3480_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40123-023-00830-w","volume":"13","author":"A Giocanti-Aur\u00e9gan","year":"2024","unstructured":"Giocanti-Aur\u00e9gan A, Donati S, Hoerauf H, Allmeier H, Rittenhouse KD, Machewitz T et al (2024) Real-world management of macular edema secondary to retinal vein occlusion with intravitreal aflibercept: 24-month results from the AURIGA observational study. Ophthalmol Ther 13:179\u2013203. https:\/\/doi.org\/10.1007\/s40123-023-00830-w","journal-title":"Ophthalmol Ther"},{"key":"3480_CR39","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/17512433.2018.1507735","volume":"11","author":"S Sangroongruangsri","year":"2018","unstructured":"Sangroongruangsri S, Ratanapakorn T, Wu O, Anothaisintawee T, Chaikledkaew U (2018) Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis. Expert Rev Clin Pharmacol 11:903\u2013916. https:\/\/doi.org\/10.1080\/17512433.2018.1507735","journal-title":"Expert Rev Clin Pharmacol"},{"key":"3480_CR40","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/jcm11071834","volume":"11","author":"F Matonti","year":"2022","unstructured":"Matonti F, Korobelnik JF, Dot C, Gualino V, Soler V, Mrejen S et al (2022) Comparative effectiveness of intravitreal anti-vascular endothelial growth factor therapies for managing neovascular age-related macular degeneration: a meta-analysis. J Clin Med 11:1834. https:\/\/doi.org\/10.3390\/jcm11071834","journal-title":"J Clin Med"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03480-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:16Z","timestamp":1766167516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3480"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03480-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0\n                      \n                      a\u2013l.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the hospital (CGH-P112040).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"96"}}